High Impact Pharmaceuticals

Event Details

When: May 19, 2022 @ 2:00PM EDT On-Demand Where: Online Event Online Event

How are drugs priced? What drugs are the leading cause of price increases? What matters more - the drug or the utilization? And what should you be doing to help keep your program effective and your claimants safe and on the road to recovery? Nikki Wilson, Pharm.D./MBA, Clinical Product Director, answers all these questions and more in this popular webinar. Wilson says, “If you’re controlling appropriate utilization, you also control price in a number of ways. Through valuable data analytics, enhanced technology applications, and various clinical programs that drive patient safety, we’re starting to get to this future state of really managing total claims cost and really driving outcomes through clinical management in general.”

This webinar has passed. If you missed the live presentation, you can access the webinar recording to the right.

Presenters

Nikki Wilson, Pharm.D./MBA, Clinical Product Director

Watch On-Demand

Please note that you can not receive CE credits for watching past webinars.

More stories

Workers' Comp Article

Specialty Solutions Spotlight: When Home Health Referrals Need a Closer Look

Home health can be a critical part of recovery, but it should not run on autopilot. The issue for adjusters is knowing when the ordered services no longer match the injured employee’s current needs, recovery progress or claim goals. A closer look can prevent unnecessary service hours, prolonged dependency, and care that is either too much or too little for the situation.

Workers' Comp Article

Ask The Pharmacist: Why Migraine Medications in Work Comp Deserve a Closer Review

Migraine headaches can be disabling, difficult to document and costly to treat. In workers’ compensation, they also create claim complexity when causation, medication choice or treatment progress is not clearly supported.

Workers' Comp Article

In-Network and Out-of-Network Trends

This analysis provides a comprehensive examination of prescription utilization across both in-network and out-of-network channels including retail pharmacies, mail-order services, and paper-based medical bill submissions. This dual-lens approach captures the full prescription landscape that extends beyond traditional pharmacy benefit management reporting, revealing critical cost and utilization patterns across all jurisdictions. While in-network channels demonstrate the real-time effectiveness of integrated clinical controls and cost management strategies, out-of-network data, often representing acute treatment episodes captured through medical bill review, exposes significant cost management opportunities and pricing anomalies. Together, these perspectives illuminate where pharmacy dollars are spent, how prescriptions are managed, and where targeted interventions can drive the greatest impact on both clinical outcomes and costs.

Disability White Paper

Beyond the Return Date

A return-to-work plan can be medically sound and still fall short. The employee may be released to return, restrictions may be documented and accommodations may be approved. But a return sustainable? The goal is to help employees return in a way that is sustainable.

General Liability Article

What Causes Bodily Injury Claim Overpayments and How to Prevent Them

Learn why bodily injury claims are overpaid and how consistent demand evaluation improves negotiation outcomes and reduces claim leakage

Workers' Comp Article

Life After Amputation: Coordinating Advanced Recovery Options

Catastrophic case management supports amputation recovery by coordinating prosthetic planning, rehabilitation and practical resources for injured employees.